The listing includes all active grants handled through the USC Dept. of Contracts & Grants. This information is updated on a quarterly basis. This listing is not intended to be a definitive source for the amount of grant awards, which should be obtained directly from the Department of Contracts and Grants. Users of this data are reminded also that there is a significant amount of grant activity not handled through the Department of Contracts & Grants and that this data is absent from this listing.
|
Administration Medicine |
HENDERSON, BRIAN E. |
Minority Predoctoral
Fellowship Program |
8/7/2006 |
7/31/2011 |
$41271.00 |
National Heart, Lung, and
Blood Institute |
|
Anesthesiology |
GOLD, MICHELE |
Nurse Anesthesia
Traineeship Program |
7/1/2003 |
6/30/2008 |
$21760.00 |
Health Resources &
Services Administration |
|
Anesthesiology |
GOLD, MICHELE |
Advanced Education Nursing
Traineeship |
7/1/2002 |
6/30/2008 |
$4764.00 |
Health Resources &
Services Administration |
|
Biochemistry |
JOHNSON, DEBORAH |
Novel Targets that are
Deregulated by Loss of PTEN |
2/6/2006 |
12/31/2010 |
$416332.00 |
National Cancer Institute |
|
Biochemistry |
JOHNSON, DEBORAH |
TATA Binding Protein, A
Novel Target of EGFR Signaling |
5/10/1997 |
4/30/2010 |
$838571.50 |
National Cancer Institute |
|
Biochemistry |
LEVY, DANIEL |
Function and Expression of
the Bile Acid Transport Protein, M-Epoxide Hydrolase |
2/15/2006 |
1/31/2011 |
$593235.91 |
National Institute of
Diabetes & Digestive & Kidney Diseases |
|
Biochemistry |
MARKLAND,JR.,F.; SWENSON,
S. D.; MOATS, R. A. |
Development of a
Multifaceted Ovarian Cancer Therapeutic and Imaging Agent |
4/1/2007 |
3/31/2010 |
$453428.00 |
Department of Defense |
|
Biochemistry |
MARKLAND,JR.,FRANCIS |
Liposomal Disintegrin:
Novel and Effective Antitumor Agent |
5/4/2007 |
4/30/2008 |
$120546.00 |
Molecular Express, Inc. |
|
Biochemistry |
STALLCUP, M.; JOHNSON, D.;
WATANABE, R. M. |
Training in Genetic,
Molecular, and Cellular Biology |
7/1/2003 |
6/30/2008 |
$196144.00 |
National Institute of
General Medical Sciences |
|
Biochemistry |
STALLCUP, MICHAEL |
Protein Methyltransferases
as Transcription Coactivators |
1/15/1999 |
12/31/2007 |
$892093.00 |
National Institute of
Diabetes & Digestive & Kidney Diseases |
|
Biochemistry |
STALLCUP, MICHAEL |
Nuclear Receptor
Coactivators GRIP1, CoCoA, and Flil |
7/1/1990 |
12/31/2009 |
$736677.00 |
National Institute of
Diabetes & Digestive & Kidney Diseases |
|
Biochemistry |
SWENSON, S. D.;
MARKLAND,JR.,F.; MOATS, R.A. |
rADDs: Novel Disintegrins
Targeting Breast Cancer |
7/1/2006 |
12/31/2007 |
$81500.00 |
California Breast Cancer
Research Program |
|
Cancer Center |
AN, WOOJIN |
Role of Histone Acetylation
in Transcription Regulation |
1/1/2006 |
12/31/2007 |
$75000.00 |
Early (Margaret E.) Medical
Research Trust |
|
Cancer Center |
BAEZCONDE-GARBANATI, |
Cancer Information Service
(CIS) - Partnership Program Office |
10/15/1999 |
1/14/2010 |
$608879.00 |
Northern California Cancer
Center |
|
Cancer Center |
CASAGRANDE, JOHN T. |
CRIC PC Support and
Programmer |
1/1/2005 |
2/28/2008 |
$226945.00 |
USC/Norris Cancer Center
Foundation |
|
Cancer Center |
COETZEE, GERHARD A. |
Steroid-Independent
signaling of the AR in hormone independent prostate cancer |
2/1/2004 |
12/31/2008 |
$100000.00 |
Prostate Cancer Foundation |
|
Cancer Center |
COETZEE, GERHARD A. |
The Role of Transcription
Factors, RUNX2 and AR, in Prostate Cancer |
1/1/2007 |
1/31/2010 |
$97732.00 |
U.S. Army Medical Research
and Materiel Command |
|
Cancer Center |
COETZEE, GERHARD A. |
Unterstanding
Castrate-Resistant Prostate Cancer |
2/1/2006 |
1/31/2008 |
$100000.00 |
Prostate Cancer Foundation |
|
Cancer Center |
COETZEE, GERHARD A.;
FRENKEL, BARUCH |
AR and RUNX2 Target Genes
in Prostate Cancer |
2/1/2006 |
12/31/2010 |
$569951.00 |
National Cancer Institute |
|
Cancer Center |
COETZEE, GERHARD A.; RICE,
JUDD CHRISTOPHER |
Androgen Receptor-Mediated
Escape Mechanisms from Androgen Ablation Therapy |
10/1/2004 |
10/31/2008 |
$610313.00 |
U.S. Army Medical Research
and Materiel Command |
|
Cancer Center |
DANENBERG, PETER |
Methylated genes as Serum
Biomarkers for Lung Cancer |
5/1/2004 |
4/30/2009 |
$710961.00 |
Sloan-Kettering Institute
for Cancer Research |
|
Cancer Center |
DUBEAU, LOUIS; MAXSON,
ROBERT E. |
Cell Non-Autonomous Mode of
Tumor Suppression by BRCA1 |
8/1/2006 |
7/31/2010 |
$456208.00 |
National Cancer Institute |
|
Cancer Center |
GOLDKORN, AMIR |
Targeting Cancer with
Telomerase Interference |
9/1/2007 |
8/31/2012 |
$128993.00 |
National Cancer Institute |
|
Cancer Center |
GOLDKORN, AMIR |
Targeting Cancer with
Telomerase Interference |
3/1/2007 |
12/31/2007 |
$22176.95 |
American Society Of
Clinical Oncology |
|
Cancer Center |
HOLMES, DENNIS R. |
The USC-Charles R. Drew
Medical Society Clinical Trial Initiative |
8/1/2006 |
7/31/2008 |
$466781.00 |
USC/Norris Cancer Center
Foundation |
|
Cancer Center |
HONG, YOUNG-KWON |
A Lymphatic-Specific
Fluorescent Transgentic Animal Model |
6/1/2006 |
5/31/2008 |
$441004.00 |
National Heart, Lung, and
Blood Institute |
|
Cancer Center |
HONG, YOUNG-KWON |
Lymphatic Reprogramming of
Embryonic Stem Cells for a Cell-Based Theraphy for Lymphedema in Breast
Cancer Patients |
9/1/2007 |
9/30/2008 |
$122250.00 |
U.S. Army Medical Research
and Materiel Command |
|
Cancer Center |
HONG, YOUNG-KWON |
Dissection of the Molecular
Mechanism Underlying the Lymphatic Reprogramming of Vascular endothelial
Cells by Kaposi's Sarcoma Herpes Virus (KSHV) |
1/1/2006 |
12/31/2007 |
$75000.00 |
Early (Margaret E.) Medical
Research Trust |
|
Cancer Center |
HONG, YOUNG-KWON |
Lymphatic Reprogramming of
Vascular Endothelial Cells by Kaposi's Sarcoma Herpes Virus (KSHV) |
7/1/2006 |
6/30/2008 |
$100000.00 |
Concern Foundation for
Cancer Research |
|
Cancer Center |
JONES, P. A.;LEE, A.
S.;WEBER, J.;SIEGEL, S.; |
USC/Norris Comprehensive
Cancer Center (CORE) Support |
12/1/1996 |
11/30/2010 |
$13657218.82 |
National Cancer Institute |
|
Cancer Center |
JONES, PETER A. |
Common Equipment Recharge
Account - USC Norris Comp Cancer Center |
12/1/2003 |
6/30/2008 |
$1.00 |
University of Southern
California - Internal |
|
Cancer Center |
JONES, PETER A. |
Determining the Role the
Swi/Snf Complex Plays in Epigenetics |
1/1/2007 |
12/31/2007 |
$44000.00 |
American Cancer Society,
Inc. |
|
Cancer Center |
JONES, PETER A. |
De Novo DNA Methylation in
Bladder Cancer |
3/1/2000 |
1/31/2010 |
$1168059.44 |
National Cancer Institute |
|
Cancer Center |
JONES, PETER A. |
Mechanisms of De Novo
Methylation in Cancer |
9/17/1999 |
4/30/2009 |
$1801304.60 |
National Cancer Institute |
|
Cancer Center |
JONES, PETER A. |
Training Program in Viral
and Chemical Carcinogenesis |
8/1/1979 |
6/30/2008 |
$297188.00 |
National Cancer Institute |
|
Cancer Center |
JONES, PETER A. |
Lynne Cohen Preventive Care
Clinic for Women's Cancers |
4/1/2004 |
11/30/2007 |
$385012.44 |
Cohen (Lynne) Foundation
for Ovarian Cancer Res. |
|
Cancer Center |
JONES, PETER A. |
Glassware Recharge Account
- USC Norris Comp Cancer Center |
12/1/2003 |
6/30/2008 |
$1.00 |
University of Southern
California - Internal |
|
Cancer Center |
JONES, PETER A. |
Common Photocopy Recharge
Account - USC Norris Comp Cancer Center |
12/1/2003 |
6/30/2008 |
$1.00 |
University of Southern
California - Internal |
|
Cancer Center |
JONES, PETER A. |
Molecular Mechansims of
Human Bladder Carcinogenesis |
9/13/2002 |
8/31/2008 |
$6828851.00 |
National Cancer Institute |
|
Cancer Center |
JONES, PETER A. |
Innovative Tailored
Therapies Initiative |
4/8/2002 |
3/31/2008 |
$5240000.00 |
Whittier (L. K.) Foundation |
|
Cancer Center |
JONES, PETER A.;
CASAGRANDE, JOHN T. |
Cancer Research Informatics
Core -Norris Comp Cancer Center |
7/1/2006 |
6/30/2008 |
$1.00 |
University of Southern
California - Internal |
|
Cancer Center |
JONES, PETER A.; COZEN,
WENDY |
Translational Pathology -
Slide Recharge Account |
12/1/2003 |
6/30/2008 |
$1.00 |
University of Southern
California - Internal |
|
Cancer Center |
JONES, PETER A.; GRAY, J.
DIXON |
Flow Cytometry Recharge
Account - USC Norris Comp Cancer Center |
12/1/2003 |
6/30/2008 |
$1.00 |
University of Southern
California - Internal |
|
Cancer Center |
JONES, PETER A.; HINTON,
DAVID R. |
Conofocal Microscope CORE -
Norris Comp Cancer Center |
12/1/2003 |
6/30/2008 |
$1.00 |
University of Southern
California - Internal |
|
Cancer Center |
JONES, PETER A.; KAST,
WIJBE M. |
Immune Monitoring Core -
USC Norris Comp Cancer Center |
2/1/2005 |
6/30/2008 |
$1.00 |
University of Southern
California - Internal |
|
Cancer Center |
JONES, PETER A.; LAIRD,
PETER W. |
DNA Methylation Core - USC
Norris Comp CAncer Center |
12/1/2003 |
6/30/2008 |
$1.00 |
University of Southern
California - Internal |
|
Cancer Center |
JONES, PETER A.; MARTIN,
SUE ELLEN |
Translational Pathology -
Soft Recharge Account - USC Norris Comp Cancer Center |
12/1/2003 |
6/30/2008 |
$1.00 |
University of Southern
California - Internal |
|
Cancer Center |
JONES, PETER A.; MAXSON,
ROBERT E. |
Transgenic Mouse Recharge
Account - USC Norris Comp Cancer Center |
12/1/2003 |
6/30/2008 |
$1.00 |
University of Southern
California - Internal |
|
Cancer Center |
JONES, PETER A.; MC MILLAN,
MINNIE |
DNA Core Recharge Account -
USC Norris Comp CAncer Center |
12/1/2003 |
6/30/2008 |
$1.00 |
University of Southern
California - Internal |
|
Cancer Center |
JONES, PETER A.; TOKES,
ZOLTAN A. |
Cell Culture Recharge
Account - USC Comp Cancer Center |
12/1/2003 |
6/30/2008 |
$1.00 |
University of Southern
California - Internal |
|
Cancer Center |
JONES, PETER A.; VAN DEN
BERG, DAVID |
Genomics Recharge Account -
USC Norris Comp Cancer Center |
12/1/2003 |
6/30/2008 |
$1.00 |
University of Southern
California - Internal |
|
Cancer Center |
KAST, WIJBE M. |
VLP Vaccines Against
HPV-Transformed Cells |
6/1/1997 |
3/31/2008 |
$1287172.56 |
National Cancer Institute |
|
Cancer Center |
KAST, WIJBE M. |
A New Approach for
Dendritic Cell-Based Cancer Immunotherapy for Cervical Cancer |
1/1/2004 |
12/31/2007 |
$300000.00 |
V-Foundation for Cancer
Research |
|
Cancer Center |
KAST, WIJBE M. |
Genetic Vaccination
Approaches |
9/1/2003 |
11/30/2007 |
$518540.50 |
Wyeth Laboratories |
|
Cancer Center |
KAST, WIJBE M. |
Prostate Cancer
Immunotherapy through Breaking of Immunological Tolerance |
1/1/2007 |
12/31/2007 |
$75000.00 |
Early (Margaret E.) Medical
Research Trust |
|
Cancer Center |
KAST, WIJBE M. |
Cervical Cancer Treatment
through HPV Virus like particles |
9/1/2003 |
4/30/2008 |
$1264656.00 |
University of Chicago |
|
Cancer Center |
LADNER, R. D.; LENZ,
HEINZ-JOSEF ; GROSHEN, . |
Histone Deacetylase
Inhibitors for the Treatment of Metastatic Colon Cancer |
7/1/2006 |
6/30/2008 |
$250000.00 |
American Association for
Cancer Research-Gertrude |
|
Cancer Center |
LADNER, ROBERT D. |
dUTPase as a Target for
Drug Discovery |
5/1/2004 |
12/31/2007 |
$289283.00 |
National Cancer Institute |
|
Cancer Center |
LADNER, ROBERT D.; NEAMATI,
NOURI |
dUTPase as a Target for
Drug Development |
7/1/2006 |
6/30/2008 |
$50000.00 |
Concern Foundation for
Cancer Research |
|
Cancer Center |
LAIRD-OFFRINGA, I.; HACIA,
J. G.; LAIRD, P. W. |
DNA Methylation Changes
During Development and Progression of Lung Adenocarcinoma |
7/1/2007 |
5/31/2012 |
$312019.00 |
National Cancer Institute |
|
Cancer Center |
LAIRD-OFFRINGA, ITE |
Rapid Screening of DNA
Methylation Markers for Accurate Molecular Diagnosis of Mesothelioma |
1/1/2006 |
12/31/2007 |
$100000.00 |
Mesothelioma Applied
Research Foundation |
|
Cancer Center |
LAIRD-OFFRINGA, ITE |
Epigenetic Alterations
during Progression from Atypical Adenomatous Hyperplasia to Bronchioalveolar
Carcinoma and Lung Adenocarcinoma |
11/1/2006 |
12/31/2008 |
$50000.00 |
Joan's Legacy Lung Cancer
Foundation |
|
Cancer Center |
LANDOLPH, JOSEPH R. |
Genotoxicity of Nickel
Metal Grinding Dust, Spherical Particles of Elemental Nickel, Fine Particles
of Nickel Compacts and Nickel Sulfate by Short-Term Assays in C3H/10T1/2 C1 8
Mouse Embryo Cells |
8/1/2004 |
12/31/2007 |
$56000.00 |
Nickel Producers Environmental
Research Association |
|
Cancer Center |
LEE, AMY S. |
A Novel Transgenic Mouse
Model for Diabetes |
5/1/2005 |
4/30/2008 |
$321548.00 |
National Institute of
Diabetes & Digestive & Kidney Diseases |
|
Cancer Center |
LEE, AMY S. |
American Cancer Society
Institutional Research Grant |
1/1/2006 |
12/31/2008 |
$240000.00 |
American Cancer Society,
Inc. |
|
Cancer Center |
LEE, AMY S. |
A New Mechanism for
Estrogen-Starvation Resistance in Breast Cancer |
8/1/2007 |
8/31/2010 |
$489000.00 |
U.S. Army Medical Research
and Materiel Command |
|
Cancer Center |
LEE, AMY S. |
Mechanism of Anti-Apoptotic
Function of GRP78/Bip |
8/1/2005 |
5/31/2009 |
$832041.00 |
National Cancer Institute |
|
Cancer Center |
LEE, AMY S. |
Stress Induction of Glucose
Regulated protein GRP78/BiP |
4/1/1980 |
5/31/2012 |
$492497.00 |
National Cancer Institute |
|
Cancer Center |
LENZ, HEINZ-JOSEF |
Southwest Oncology Group
Operations Office Grant CHAIR GI Translational Medicine Committee |
1/1/2007 |
12/31/2007 |
$20567.00 |
University of Michigan |
|
Cancer Center |
LENZ, HEINZ-JOSEF |
SWOG S0415: Cetuximab as a
Second Line Therapy in Patients with Metastatic Esophageal Cancer, Phase II |
3/1/2006 |
2/28/2008 |
$48185.00 |
Southwest Oncology Group |
|
Cancer Center |
LENZ, HEINZ-JOSEF |
SWOG GI Cancer TMC
Development Funds |
1/1/2007 |
12/31/2008 |
$27500.00 |
The Hope Foundation |
|
Cancer Center |
LENZ, HEINZ-JOSEF |
SWOG S0124: Randomized
Phase III Trial of Cisplatin and Irinotecan (NNSC-616348) Versus Cisplatin
and Etoposide in patients with extensive stage small cell lung cancer
(E-SCLC) |
4/1/2007 |
3/31/2012 |
$44581.00 |
Southwest Oncology Group |
|
Cancer Center |
LENZ, HEINZ-JOSEF |
SWOG S0205: A Phase III
Randomized Open-Label Study Comparing Gemcitabine plus IMC-225 (Cetuximab)
versus Gemcitabine as First Line Therapy of patients with Advanced Pancreas
Cancer |
9/1/2006 |
2/29/2008 |
$64080.00 |
Southwest Oncology Group |
|
Cancer Center |
LENZ, HEINZ-JOSEF |
Southwest Oncology Group
Operations Office Grant Vice-Chair Gastrointestinal (GI) Cancer Committee |
4/1/2004 |
12/31/2009 |
$10021.00 |
University of Michigan |
|
Cancer Center |
LENZ, HEINZ-JOSEF |
Early Therapeutics
Development with Phase II Emphasis |
1/1/2006 |
12/31/2008 |
$225285.10 |
University of California,
Davis |
|
Cancer Center |
LENZ, HEINZ-JOSEF |
SWOG Member Institution
Program |
4/1/2004 |
3/31/2008 |
$173230.00 |
Southwest Oncology Group |
|
Cancer Center |
LENZ, HEINZ-JOSEF |
SWOG S0414: Cetuximab Plus
Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for locally advanced
(non-metastatic) clinically unresectable Esophageal Cancer: A Phase II Trial
with Molecular Correlates |
3/1/2006 |
2/28/2008 |
$38925.00 |
Southwest Oncology Group |
|
Cancer Center |
LENZ, HEINZ-JOSEF |
Phase I Molecular and
Clinical Pharmacodynamic Trials |
2/1/2003 |
1/31/2008 |
$167182.00 |
Beckman Research Institute
of the City of Hope |
|
Cancer Center |
LENZ, HEINZ-JOSEF; QUINN,
DAVID I |
Southwest Oncology Group
Supplemental Funding Request for High Accrual |
2/1/1993 |
12/31/2009 |
$278307.00 |
National Cancer Institute |
|
Cancer Center |
LENZ, HEINZ-JOSEF; SHERROD,
A.; DANENBERG, P. |
Rectal Cancer: Molecular
Markers of Outcome and Toxicity |
3/29/2004 |
2/29/2008 |
$1442444.00 |
National Cancer Institute |
|
Cancer Center |
LIEBER, MICHAEL |
Normal and Mutant Lymphoid
V(D)J Recombinase |
9/1/2007 |
8/31/2011 |
$285049.00 |
National Institute of
General Medical Sciences |
|
Cancer Center |
LIEBER, MICHAEL |
Mechanism of DNA
Recombination at Class Swith Sequences |
9/1/1998 |
12/31/2010 |
$589310.99 |
National Institute of
General Medical Sciences |
|
Cancer Center |
LIEBER, MICHAEL |
Mechanism of Human
Chromosomal Translocations |
1/1/1990 |
8/31/2010 |
$1289058.90 |
National Cancer Institute |
|
Cancer Center |
LIEBER, MICHAEL |
Mechanism of DNA
Recombination at Class Switch Sequences |
8/1/2003 |
7/31/2009 |
$1278115.00 |
National Cancer Institute |
|
Cancer Center |
MAXSON, ROBERT E. |
Twist and Msx2 in Boundary
Formation and Craniosynostosis |
8/1/2005 |
7/31/2010 |
$1190765.00 |
National Institute of
Dental and CranioFacial Rese |
|
Cancer Center |
MAXSON, ROBERT E.; SUCOV,
HENRY M. |
Expression and Function of
Homeobox Genes |
2/1/1989 |
1/31/2008 |
$1915363.06 |
National Institute of
Dental and CranioFacial Rese |
|
Cancer Center |
MC MILLAN, MINNIE |
Mass Spectrometry Study of
a Toleragenic Peptidefor Treating Multiple Sclerosis |
4/1/2007 |
3/31/2008 |
$44000.00 |
National Multiple Sclerosis
Society |
|
Cancer Center |
PINSKI, J. K.;GROSHEN,
S.;HAWES, D; DANENBERG, P. |
Prognostic Molecular
Markers for Prostate Cancer |
11/1/2005 |
11/30/2008 |
$610453.00 |
Department of Defense
Medical Research Acquisition Activity |
|
Cancer Center |
PINSKI, J. K.;HAWES,
D.;INGLES, S.;PIKE, M. |
Prostatic Neuroendocrine
Differentiation in Different Ethnic Groups |
7/1/2006 |
6/30/2010 |
$720000.00 |
American Cancer Society,
Inc. |
|
Cancer Center |
PINSKI, JACEK K. |
A Novel Therapy for
Prostate Cancer Based on the Distintegrin Controtrostatin |
1/12/2004 |
2/11/2008 |
$609010.00 |
U.S. Army Medical Research
and Materiel Command |
|
Cancer Center |
QUINN, DAVID I |
Clinical Investigations
Support Office |
10/1/2004 |
12/31/2007 |
$1408900.50 |
USC/Norris Cancer Center
Foundation |
|
Cancer Center |
RICE, JUDD CHRISTOPHER |
Molecular Mechanisms of
Gene Silencing by H4 Methylation |
8/1/2007 |
7/31/2012 |
$309700.00 |
National Institute of
General Medical Sciences |
|
Cancer Center |
RICE, JUDD CHRISTOPHER |
Signaling from Chromatin:
Reading the Histone Code |
7/1/2006 |
6/30/2010 |
$120000.00 |
University of California,
San Francisco |
|
Cancer Center |
SKINNER, EILA C. |
Urological Cancer Outreach
Program |
1/1/1999 |
12/31/2007 |
$647181.00 |
Southwest Oncology Group |
|
Cancer Center |
SKINNER, EILA C. |
Selenium and Vitamin E
Chemoprevention Trial (SELECT) for Prostate Cancer |
6/1/2000 |
5/31/2013 |
$87620.00 |
Southwest Oncology Group |
|
Cancer Center |
SPICER, DARCY V. |
Cancer Genetic Counseling
Services at LAC+USC Medical Center |
10/1/2007 |
9/30/2010 |
$320100.00 |
USC/Norris Cancer Center
Foundation |
|
Cancer Center |
SPICER, DARCY V. |
NSABP Prevention Trials |
6/1/1999 |
5/31/2008 |
$41000.00 |
NSABP Foundation, Inc. |
|
Cancer Center |
WEBER, JEFFREY S. |
Cancer Research and Care
Services - Paul N. Sommer Bequest |
5/17/2005 |
4/30/2010 |
$1763500.00 |
LA County, Dept. of Health
Services |
|
Cancer Center |
ZANDI, EBRAHIM |
Signal Transduction
Mechanisms of IkB Kinase Regulation |
8/1/2002 |
7/31/2008 |
$1374758.00 |
National Institute of
General Medical Sciences |
|
Cardio Thoracic Surgery |
STARNES, VAUGHN A. |
Surgical Treatment for
Ischemic Heart Failure (STICH) Trial |
1/1/2003 |
12/31/2008 |
$21790.00 |
Duke University |
|
Cell and Neuro-Biology |
LIN, SHI-LUNG |
Functional MicroRNA (miRNA)
in Prostate Cancer |
3/1/2007 |
2/28/2008 |
$100000.00 |
Prostate Cancer Foundation |
|
Cell and Neuro-Biology |
MC NEILL, THOMAS H. |
Physical Activity,
Antidepressants and BDNF Induction |
7/1/2004 |
5/31/2009 |
$237252.00 |
California State University
Los Angeles |
|
Cell and Neuro-Biology |
MC NEILL, THOMAS H. |
Dopaminergic Modulation of
Corticostriatal Plasticity |
2/15/2005 |
12/31/2008 |
$955332.00 |
National Institute of
Neurological Disorders and Stroke |
|
Cell and Neuro-Biology |
MC NEILL, THOMAS H. |
Exercise and Antidepressant
Drug Treatment in Brain Injury |
2/15/2005 |
1/31/2008 |
$352777.00 |
National Institute of
Neurological Disorders and Stroke |
|
Cell and Neuro-Biology |
MC
NEILL,T.H.;WINSTEIN,C.;RIZZO,A.;MCLAUGHLIN,M. |
New Directions in Stroke
Neurorehabilitation |
9/28/2004 |
7/31/2008 |